Dr. Carrie L. Kovarik, MD

Dr. Kovarik practices at Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr) in Philadelphia, Pennsylvania.

Dr. Kovarik's NPI, 1881600955, was assigned on July 31, 2006. Dr. Kovarik graduated from Baylor College of Medicine in 2001. Dr. Kovarik holds Pennsylvania license MD428390.

Dr. Kovarik's primary practice is Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr), at 3400 Spruce Street, White Bldg 1st Flr, Philadelphia, PA 19104.

Dr. Kovarik's primary practice is Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr) in Philadelphia, Pennsylvania. Dr. Kovarik is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Kovarik to 4 more hospitals, each named with a free account. Dr. Kovarik's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kovarik practices, 6 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Kovarik's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Kovarik is licensed in Pennsylvania.

CMS data shows 5,338 Medicare services from Dr. Kovarik across 12 procedure codes in 2024, for 2,813 Medicare patients. Medicare paid $138,603 for them.

CMS counts 2,813 Medicare patients who saw Dr. Kovarik in 2024. The largest group is 65 to 74, with 1,243 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kovarik's median patient age at 70, with 53% women.

In 2024, Dr. Kovarik wrote 128 Medicare Part D claims for 21 patients. 91% of them were for generic drugs. CMS names the drug for 91 of them, across 7 drugs with 11 or more claims each, at $6,218 in total drug cost. In 2022, CMS named 26 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Kovarik for performance year 2024, reported as part of a group. Dr. Kovarik accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of removal or shaving of skin growth by Dr. Kovarik, more than 64% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 165 papers to Dr. Kovarik, published from 2009 to 2025. 2018 was the busiest year, with 15. The most frequent topics are Dermatology, Telemedicine and Skin Diseases. Dr. Kovarik has published most often in J Am Acad Dermatol. Dr. Kovarik's most frequent co-authors are Jules B. Lipoff, MD, Parth S. Mehta, MD and Emily Y. Chu, MD.

CMS Open Payments shows 2 general payments to Dr. Kovarik from 1 drug or device company from 2017 to 2019. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $36.

Dr. Kovarik graduated from Baylor College of Medicine in 2001.